Literature DB >> 11099894

The importance of non-transferrin bound iron in disorders of iron metabolism.

W Breuer1, C Hershko, Z I Cabantchik.   

Abstract

The concept of non-transferrin bound iron (NTBI) was introduced 22 years ago by Hershko et al. (Brit. J. Haematol. 40 (1978) 255). It stemmed from a suspicion that, in iron overloaded patients, the large amounts of excess iron released into the circulation are likely to exceed the serum transferrin (Tf) iron-binding capacity (TIBC), leading to the appearance of various forms of iron not bound to Tf. In accordance with this assumption, NTBI was initially looked for and detected in patients with > or = 100% Tf-saturation. As techniques for its detection became more sophisticated and sensitive, NTBI was also found in conditions where Tf was not fully saturated, leading to a revision of the original view of NTBI as a simple spillover phenomenon. In this review, we will discuss some of the properties of NTBI, methods for its detection, its significance and potential value as an indicator for therapeutic regimens of iron chelation and supplementation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11099894     DOI: 10.1016/s0955-3886(00)00087-4

Source DB:  PubMed          Journal:  Transfus Sci        ISSN: 0955-3886


  60 in total

Review 1.  The Labile Side of Iron Supplementation in CKD.

Authors:  Itzchak Slotki; Zvi Ioav Cabantchik
Journal:  J Am Soc Nephrol       Date:  2015-05-21       Impact factor: 10.121

Review 2.  β-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies.

Authors:  Stefano Rivella
Journal:  Haematologica       Date:  2015-04       Impact factor: 9.941

3.  Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency.

Authors:  Bernd Bokemeyer; Annette Krummenerl; Christian Maaser; Stefanie Howaldt; Michael Mroß; Nick Mallard
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-04       Impact factor: 2.441

4.  Association between neonatal iron overload and early human brain development in premature infants.

Authors:  Sanjiv B Amin; Gary Myers; Hongyue Wang
Journal:  Early Hum Dev       Date:  2012-02-18       Impact factor: 2.079

5.  Enhanced Electrochemical Sensing with Carbon Nanotubes Modified with Bismuth and Magnetic Nanoparticles in a Lab-on-a-Chip.

Authors:  Preetha Jothimuthu; Joe L Hsu; Robert Chen; Mohammed Inayathullah; Venkata Raveendra Pothineni; Antony Jan; Geoffrey C Gurtner; Jayakumar Rajadas; Mark R Nicolls
Journal:  ChemNanoMat       Date:  2016-07-25       Impact factor: 3.154

6.  Small molecule inhibitors of divalent metal transporter-1.

Authors:  Peter D Buckett; Marianne Wessling-Resnick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-29       Impact factor: 4.052

Review 7.  Oxidative Stress in β-Thalassemia.

Authors:  Eitan Fibach; Mutaz Dana
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

8.  Iron overload in sickle cell disease.

Authors:  Radha Raghupathy; Deepa Manwani; Jane A Little
Journal:  Adv Hematol       Date:  2010-05-17

9.  Source-dependent intracellular distribution of iron in lens epithelial cells cultured under normoxic and hypoxic conditions.

Authors:  Małgorzata Goralska; Steven Nagar; Lloyd N Fleisher; Philip Mzyk; M Christine McGahan
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-19       Impact factor: 4.799

10.  Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with beta-thalassaemia.

Authors:  Shahina Daar; Anil Pathare; Hanspeter Nick; Ulrike Kriemler-Krahn; Abdel Hmissi; Dany Habr; Ali Taher
Journal:  Eur J Haematol       Date:  2008-12-22       Impact factor: 2.997

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.